More interestingly, two of the regions (7q21.12 and 8q24.22) were significantly amplified in malignant samples, which lead us to discover the association of MYC, a known marker of malignancy, with the development of IPMN. This evidence concerns the gene MYC and pancreatic intraductal papillary-mucinous neoplasm.